TY - JOUR
T1 - Deletion status of p16 in effusion smear preparation correlates with that of underlying malignant pleural mesothelioma tissue
AU - Hida, Tomoyuki
AU - Matsumoto, Shinji
AU - Hamasaki, Makoto
AU - Kawahara, Kunimitsu
AU - Tsujimura, Tohru
AU - Hiroshima, Kenzo
AU - Kamei, Toshiaki
AU - Taguchi, Kenichi
AU - Iwasaki, Akinori
AU - Oda, Yoshinao
AU - Honda, Hiroshi
AU - Nabeshima, Kazuki
N1 - Publisher Copyright:
© 2015 Japanese Cancer Association.
PY - 2015/11/1
Y1 - 2015/11/1
N2 - Differentiating malignant pleural mesothelioma (MPM) cells morphologically from reactive mesothelial hyperplasia cells is problematic. Homozygous deletion (HD) of p16 (CDKN2A), detected by FISH, is a good marker of malignancy and is useful to differentiate between these cells. However, the correlation between the p16 status of effusion smears and that of the underlying MPM tissues has not been investigated. We used p16-specific FISH to investigate 20 cases of MPM from which both effusion cytologic smears and histologic specimens were available. In five cases, histologic specimens included both an invasive component and surface mesothelial proliferation. In 14 cases (70%), MPM cells in both tissue sections and effusion smears were p16 HD-positive. Conversely, MPM cells in the remaining six tumors (30%) were p16 HD-negative in both tissue sections and effusion smears. For all five MPM cases with surface mesothelial proliferations and invasive components, the effusion smears, surface mesothelial proliferations, and invasive MPM components all displayed p16 deletion. Moreover, the extent to which p16 was deleted in smears highly correlated with the extent of p16 deletion in tissues. The p16 deletion percentages were also similar among smears, tissue surface proliferations, and invasive components. In cases with clinical and radiologic evidence of a diffuse pleural tumor, detection of p16 deletion in cytologic smear samples may permit MPM diagnosis without additional tissue examination. However, the absence of p16 deletion in cytologic smear samples does not preclude MPM. This study demonstrated the correlation between the p16 deletion status of effusion cytology and that of underlying malignant pleural mesothelioma (MPM) tissues by fluorescence in situ hybridization (FISH) analysis for MPM cases in which both materials were available. To the best of our knowledge, this is the first study to evaluate the correlation of p16 FISH status in MPM between cytologic and histologic specimens. If p16 FISH status of cytologic preparations can predict that of the underlying MPM, it may be possible to diagnose MPM in cytologic preparations in cases with clinical and radiological evidence of a diffuse pleural tumor.
AB - Differentiating malignant pleural mesothelioma (MPM) cells morphologically from reactive mesothelial hyperplasia cells is problematic. Homozygous deletion (HD) of p16 (CDKN2A), detected by FISH, is a good marker of malignancy and is useful to differentiate between these cells. However, the correlation between the p16 status of effusion smears and that of the underlying MPM tissues has not been investigated. We used p16-specific FISH to investigate 20 cases of MPM from which both effusion cytologic smears and histologic specimens were available. In five cases, histologic specimens included both an invasive component and surface mesothelial proliferation. In 14 cases (70%), MPM cells in both tissue sections and effusion smears were p16 HD-positive. Conversely, MPM cells in the remaining six tumors (30%) were p16 HD-negative in both tissue sections and effusion smears. For all five MPM cases with surface mesothelial proliferations and invasive components, the effusion smears, surface mesothelial proliferations, and invasive MPM components all displayed p16 deletion. Moreover, the extent to which p16 was deleted in smears highly correlated with the extent of p16 deletion in tissues. The p16 deletion percentages were also similar among smears, tissue surface proliferations, and invasive components. In cases with clinical and radiologic evidence of a diffuse pleural tumor, detection of p16 deletion in cytologic smear samples may permit MPM diagnosis without additional tissue examination. However, the absence of p16 deletion in cytologic smear samples does not preclude MPM. This study demonstrated the correlation between the p16 deletion status of effusion cytology and that of underlying malignant pleural mesothelioma (MPM) tissues by fluorescence in situ hybridization (FISH) analysis for MPM cases in which both materials were available. To the best of our knowledge, this is the first study to evaluate the correlation of p16 FISH status in MPM between cytologic and histologic specimens. If p16 FISH status of cytologic preparations can predict that of the underlying MPM, it may be possible to diagnose MPM in cytologic preparations in cases with clinical and radiological evidence of a diffuse pleural tumor.
UR - http://www.scopus.com/inward/record.url?scp=84983094232&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84983094232&partnerID=8YFLogxK
U2 - 10.1111/cas.12769
DO - 10.1111/cas.12769
M3 - Article
C2 - 26291840
AN - SCOPUS:84983094232
SN - 1347-9032
VL - 106
SP - 1635
EP - 1641
JO - Cancer Science
JF - Cancer Science
IS - 11
ER -